- POSITIVE
Annual Revenue Avience Biomedicals Mar-2026 Annual Revenue is Rs 35 Cr which is growth of 20.2% YoY.
- POSITIVE
Annual Net Profit Avience Biomedicals Mar-2026 Annual Net Profit is Rs 7 Cr which is growth of 31.1% YoY.
Avience Biomedicals Ltd.
NSE: AVIENCEAvience Biomedicals Live Share Price Today, Share Analysis and Chart
aboutAvience Biomedicals was incorporated on December 23, 2019. The company is engaged in the manufacturing of in-vitro diagnostic (IVD) products and medical devices from its facility in Noida, Uttar Pradesh. Its products support the detection of diseases... Read More
263.8512.40(4.93%)
31,200
NSE Volume
NSE 20 Nov, 2026 3:31 PM
Avience Biomedicals Stock Price Ranges
Day Price Range4.9% 1 Day return | 263.8 (LTP) 251.4264 LowHigh |
|---|---|
Week Price Range4.3% 1 Week return | 263.8 (LTP) 225264 LowHigh |
Month Price Range2.2% 1 Month return | 263.8 (LTP) 225272 LowHigh |
52 Week Price Range26.8% 1 Year return | 263.8 (LTP) 222415 LowHigh |
Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Avience Biomedicals annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
48.2% | 96.9% | 35.5 | 29.5 | 16.6 | 10.9 | 10.2 | 1.2 | ||
Operating Exp. Ann. | 36.9% | 85.9% | 24.4 | 21.2 | 13.1 | 9.5 | 8.9 | 1.1 | |
Operating Profit Ann. | 98.2% | 155.6% | 10.9 | 7.7 | 3.2 | 1.4 | 1.2 | 0.1 | |
OPM Ann. % | 33.1% | 41.6% | 30.71% | 25.91% | 18.93% | 13.03% | 12.00% | 5.40% | |
37.5% | 88.2% | 26 | 22.6 | 14 | 10 | 9.2 | 1.1 | ||
EBITDA Ann. | 99.4% | 156.5% | 11.1 | 8.3 | 3.5 | 1.4 | 1.2 | 0.1 | |
EBITDA Ann. margin % | 33.4% | 35.8% | 31.23% | 28.10% | 21.22% | 13.15% | 12.02% | 6.76% | |
Interest Ann. | 26% | - | 0.6 | 0.7 | 0.4 | 0.3 | 0.2 | 0 | |
Depr. | 71% | - | 1 | 0.7 | 0.4 | 0.2 | 0.1 | 0 | |
PBT Ann. | 111.8% | 148.6% | 9.5 | 6.9 | 2.7 | 1 | 1 | 0.1 | |
Tax Ann. | 110.5% | - | 2.8 | 1.8 | 0.7 | 0.3 | 0.3 | 0 | |
112.3% | 131.9% | 6.7 | 5.1 | 2 | 0.7 | 0.7 | 0.1 | ||
Net Profit Ann. | 112.3% | 131.9% | 6.7 | 5.1 | 2 | 0.7 | 0.7 | 0.1 | |
NPM Ann. % | 43.3% | 35.3% | 19.06% | 17.77% | 12.20% | 6.48% | 7.02% | 4.20% | |
EPS Adj. latest Ann. | 111.5% | 161.8% | 12.3 | 9.4 | 3.6 | 1.3 | 1.3 | 0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
20.3%
2Y CAGR
46.2%
3Y CAGR
48.2%
5Y CAGR
96.9%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
31.4%
2Y CAGR
83%
3Y CAGR
112.3%
5Y CAGR
131.9%
Net Profit Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
15.1%
2Y CAGR
36.5%
3Y CAGR
36.9%
5Y CAGR
85.9%
Operating Expenses Annual Cr growth is lower than historical averages.
Avience Biomedicals Technical Analysis
Avience Biomedicals EMA & SMA
Bullish+3
Bullish5
Bearish2
| 5 Day | 251.3 |
|---|---|
| 10 Day | 250.2 |
| 12 Day | 250.7 |
| 20 Day | 254.7 |
| 26 Day | 258.4 |
|---|---|
| 50 Day | 269.5 |
| 100 Day | 280.0 |
Avience Biomedicals Delivery And Volume
Daily Avg. Delivery Volume %
20 Nov, 202676.9%
Week73.6%
Month74.8%
Avience Biomedicals Active Candlesticks
Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Long Line Uptrend
PositiveNeutralNegative
Avience Biomedicals Resistance and Support
259.77
Pivot
| First Resistance | 268.1 |
|---|---|
| Second Resistance | 272.3 |
| Third Resistance | 280.6 |
| First Support | 255.5 |
|---|---|
| Second Support | 247.2 |
| Third Support | 243.0 |
| Day RSI | 52 |
|---|---|
| Day MACD | -7.7 |
| Day MFI | 51.4 |
| Day MACD Signal Line | -10.1 |
Avience Biomedicals Beta
| 1 Month | 0.5 |
|---|---|
| 1 Year | - |
| 3 Month | 0.2 |
|---|---|
| 3 Year | - |
Avience Biomedicals Price Change Analysis
↑2.2%
Over 1 Month
LowHigh
225.1272
↑12.3%
Over 3 Months
LowHigh
225.1392
↑26.9%
Over 6 Months
LowHigh
222415.0
↑26.9%
Over 1 Year
LowHigh
222415.0
Avience Biomedicals Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SURESH ZUNZUNWALA | Bulk | Sell | 20 Jul 2026 | 265.55 | 42,000 | NSE |
| SURESH ZUNZUNWALA | Bulk | Purchase | 20 Jul 2026 | 245.38 | 42,000 | NSE |
| MANSI SHARE AND STOCK BROKING PRIVATE LIMITED | Bulk | Sell | 17 Jul 2026 | 222 | 65,400 | NSE |
| SETU SECURITIES PVT LTD | Bulk | Sell | 17 Jul 2026 | 222.16 | 56,400 | NSE |
| KASHMIRA AJAY PATEL | Bulk | Sell | 17 Jul 2026 | 240.99 | 37,800 | NSE |
| NIRAJ RAJNIKANT SHAH | Bulk | Sell | 17 Jul 2026 | 222.05 | 48,000 | NSE |
| SANDEEP KUMAR SAWARMAL HISARIA | Bulk | Sell | 17 Jul 2026 | 253 | 600 | NSE |
| MANSI SHARE AND STOCK BROKING PRIVATE LIMITED | Bulk | Purchase | 17 Jul 2026 | 229.06 | 18,600 | NSE |
| SETU SECURITIES PVT LTD | Bulk | Purchase | 17 Jul 2026 | 222 | 70,200 | NSE |
| SANDEEP KUMAR SAWARMAL HISARIA | Bulk | Purchase | 17 Jul 2026 | 222.46 | 100,200 | NSE |
Avience Biomedicals Corporate Actions
Avience Biomedicals Board Meetings
Avience Biomedicals past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
110 Nov 2026 | Quarterly Results | - |
207 Sep 2026 | Other business matters | To consider and approve the Notice of AGM, Boards Report and annexures for FY ended March 31, 2026. |
325 Aug 2026 | Consolidated Financial Results and Other business matters | To approve revised consolidated financial results for March 31, 2026 and other matters. |
416 Jul 2026 | Audited Results | (Revised) |
Avience Biomedicals - Company Profile
Website: www.avienbio.com
About the company - Business Profile
Avience Biomedicals was incorporated on December 23, 2019. The company is engaged in the manufacturing of in-vitro diagnostic (IVD) products and medical devices from its facility in Noida, Uttar Pradesh. Its products support the detection of diseases, infections, and medical conditions through laboratory, healthcare, and home-based diagnostic testing applications
